A narrative review of biosimilars: a continued journey from the scientific evidence to practice implementation.

Transl Lung Cancer Res · 2020 · PMC7653109 · PMID 33209630

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

The FDA biosimilar approvals show an increasing trend as follows: 2015; one approval, 2016; three approvals, 2017; five, 2018; seven and 2019; ten new biosimilars.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.